Publications
The EAU Research Foundation has published the following publications.
Search in Publications
Relationship of Comorbidities With Bacterial Spectrum and Resistance in Urosepsis: 10 year Results of the Global Prevalence of Infections Study, a multicenter study
Z. Tandogdu, R. Bartoletti, T.E. Bjerklund Johansen, T. Cai, M. Cek, M. Grabe, E. Kulchavenya, B. Koves, K. Naber, V. Menon, T. Perepanova, R. Pickard, P. Tenke, B. Wullt, F. Wagenlehner on behalf of GPIU Investigators.
The global prevalence of infections in urology study: A long-term, worldwide surveillance study on urological infections
F. Wagenlehner, Z. Tandogdu, R. Bartoletti, T. Cai, M. Cek, E. Kulchavenya, B Köves, K. Naber, T. Perepanova, P. Tenke, B Wullt, F Bogenhard, T.E. Bjerklund Johensen.
Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003–2013
Z. Tandogdu, R. Bartoletti, T. Cai, M. Çek, M. Grabe, E. Kulchavenya, B. Köves, V. Menon, K. Naber, T. Perepanova, P. Tenke, B. Wullt, T.E. Bjerklund Johansen, F. Wagenlehner.
Establishing the Evidence Bar for Molecular Diagnostics in Personalised Cancer Care
Schneider D, Bianchini G, Horgan D, Michiels S, Witjes W, Plun-Favreau J, Brand A, and Lawler M.
Infective complications after prostate biopsy: Outcome of the GPIU prostate biopsy side study 2010-2013.
Wagenlehner F, Bartoletti R, Cai T, Cek M, Grabe M, Koves E, Kulchavenya E, Naber K, Perepanova T, Pilatz Z, Tandogdu Z, Tenke P, Weidner W, Wolf J, Wullt B, Bjerklund-Johansen TE on behalf of the GPIU investigators.
Can zoledronic acid prevent bone metastases in high-risk non-metastatic prostate cancer patients? Efficacy and safety results of the Zometa European Study (ZEUS).
Wirth M, Tammela T, Cicalese V, Gomez Veiga F, Delaere K, Miller K, Tubaro A, Schulze M, Debruyne F, Huland H, Patel A, Lecouvet F, Caris C, Witjes W. A prospective, randomized, open-label, multi-national study of the European Association of Urology (EAU) in co-operation with the Scandinavian Prostate Cancer Group (SPCG) and the Arbeitsgemeinschaft für Urologische Onkologie (AUO).
ZEUS, the quest for the Holy Grail of prostate cancer bone metastases prevention continues.
Witjes WPJ, Patel A, Wirth M.
Evolution: A European registry evaluating management practices of pharmacologically treated patients with LUTS associated with BPH. Symptomatic improvement, progression and treatment discontinuation results. A comparison between European countries.
A. Tubaro, R. Berges, M. Speakman, A. de La Taille, L. Martínez-Piñeiro, A. Patel, C. Caris, W. Witjes. EAU Research Foundation, Arnhem, The Netherlands.
Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study.
Z. Tandogdu, M. Çek, F. Wagenlehner, K. Naber, P. Tenke, E. van Oostrum and T.E. Bjerklund Johansen, On behalf of the GPIU investigators.
Peri-operative Chemotherapy in Muscle Invasive Bladder Cancer: Overview and the unmet clinical need for an alternative adjuvant therapy as studied in the MAGNOLIA clinical trial.
Colombel M, Heidenreich A, Martínez-Piñeiro L, Babjuk M, Korneyev I, Surcel C, Yakovlev P, Colombo R, Radziszewski P, Witjes F, Mulders P, Schipper R, Witjes W.P.J.